This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Metastatic Cancer
and you are
over 18
years old
This is an early phase trial to determine
the dosage and safety of the new treatment.
Show me locations

The purpose

This study evaluates the safety and tolerability of different doses of an experimental treatment in participants with advanced cancer.

Provided treatments

  • Drug: LY3007113

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT01463631. The sponsor of the trial is Eli Lilly and Company and it is looking for 27 volunteers for the current phase.
Official trial title:
A Phase 1 Study of LY3007113, a p38 MAPK Inhibitor, in Patients With Advanced Cancer